Cavanagh Shawn

Avg. Two Year Performance

No purchase track record

20% Avg. Sale Return

9% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	2%	21%	57%	46%	20%
Sale Success Rate	6 of 10	6 of 10	4 of 10	4 of 10	4 of 10

Cambrex Corp.

Drugs » Biotechnology

EVP & COO:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--